Riskpilot← Back to searchSign inGet full accessORIFARM A/S
A/SActiveCVR 26058708Energivej 15Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200139 employees
Revenue 2024
DKK 1,2B
-22% vs 2023
EBITDA margin
1.6%
-1% vs 2023
Equity ratio
35.9%
Financial strength
Net profit 2024
DKK 14,9M
-21% vs 2023
| Revenue | DKK 1,2B | -22% |
| EBITDA | DKK 20M | -1% |
| Net profit | DKK 14,9M | -21% |
| Total assets | DKK 150,4M | -50% |
| Equity | DKK 53,9M | -29% |
| Employees | 39 | — |
Legal name
ORIFARM A/S
CVR number
26058708
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. april 2001
Share capital
DKK 5.100.000
Employees
39 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør og et bestyrelsesmedlem i forening eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at foretage salg af parallelimporterede lægemidler i Danmark.
Address
Energivej 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.078.460 | 1.149.174 | 1.035.134 | 1.202.590 | 1.192.494 | 1.250.457 | 1.200.155 | 1.180.912 | 1.493.622 | 1.404.798 | 1.575.946 | 1.223.777 |
| Staff expenses | -29.756 | -33.312 | -40.983 | -45.995 | -20.642 | -22.040 | -16.097 | -19.953 | -415 | -2.036 | -7.494 | -3.267 |
| EBITDA | 12.491 | 13.441 | 11.217 | 12.032 | 13.831 | 14.181 | 15.341 | 15.494 | 19.075 | 18.119 | 20.141 | 19.964 |
| Depreciation & amort. | -4.879 | -5.264 | -2.672 | -5.246 | -6.224 | -6.893 | -6.380 | -4.860 | -4.979 | -4.072 | -4.379 | -4.669 |
| EBIT | 7.612 | 8.177 | 8.545 | 6.786 | 7.607 | 7.288 | 8.961 | 10.634 | 14.096 | 14.047 | 15.762 | 15.295 |
| Net financials | -1.072 | -2.162 | -1.466 | -1.857 | -1.684 | -1.433 | -1.874 | -1.801 | -3.076 | -830 | 8.094 | 3.706 |
| Profit before tax | 6.540 | 6.015 | 7.079 | 4.929 | 5.923 | 5.855 | 7.087 | 8.833 | 11.020 | 13.217 | 23.856 | 19.001 |
| Tax | 2.067 | 1.584 | 1.637 | 1.289 | 1.499 | 1.560 | 1.991 | 2.270 | 2.830 | 3.276 | 4.982 | 4.136 |
| Net profit | 4.473 | 4.431 | 5.442 | 3.640 | 4.424 | 4.295 | 5.096 | 6.563 | 8.190 | 9.941 | 18.874 | 14.865 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 213.815 | 218.875 | 194.841 | 312.438 | 232.008 | 194.205 | 175.252 | 195.124 | 195.390 | 421.634 | 301.842 | 150.368 |
| Equity | 18.362 | 22.793 | 28.235 | 31.874 | 36.298 | 40.593 | 35.689 | 42.252 | 47.442 | 57.382 | 76.256 | 53.921 |
| Long-term debt | 0 | 0 | 0 | -3.591 | -3.638 | -3.041 | 610 | 1.842 | 0 | 0 | 0 | 0 |
| Short-term debt | 193.490 | 193.873 | 162.801 | 276.973 | 192.072 | 150.571 | 136.329 | 148.434 | 145.810 | 362.313 | 223.571 | 94.065 |
| Total debt | 193.490 | 193.873 | 162.801 | 276.973 | 192.072 | 150.571 | 136.939 | 150.276 | 145.810 | 362.313 | 223.571 | 94.065 |
EBITDA margin
1.6%
This company
15.8%
Market median
-90% vs market
20132024
Equity ratio
35.9%
This company
38.2%
Market median
+6% vs market
20132024
Return on equity
27.6%
This company
18.4%
Market median
+50% vs market
20132024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20132024
Asset turnover
8.14×
This company
1.12×
Market median
+627% vs market
20132024
Debt / equity
1.79×
This company
0.62×
Market median
-189% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TB Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
TS Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
HS Founder | Founder | 2001 | — | — |
JP Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
SE Founder | Founder | 2001 | — | — |
EJ Founder | Founder | 2001 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2003 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2005 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2003 | — | — | |
| Chairman | 2001 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ORIFARM PI A/S | Company | 100.0% | 100.0% | 2003 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Orifarm Holding A/S
ORIFARM A/S Board members of ORIFARM A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Brandhof | Chief Executive Officer | 0 companies |
| Tine Søndergaard Jensen | Chief Executive Officer | 0 companies |
| Henrik Steen Jensen | Founder | 0 companies |
| Jens Peter Nielsen | Chief Executive Officer | 0 companies |
| Steffen Ebdrup | Founder | 0 companies |
| Erik Jensen | Founder | 0 companies |
| Per Munk Laustsen | Board of Directors | 0 companies |
| Hans Carl Bøgh-Sørensen | Chairman | 0 companies |
| Mads Fink Eriksen | Board of Directors | 0 companies |
| Anders Carl Norstrand | Board of Directors | 0 companies |
| Erik Sandberg | Chairman | 0 companies |
| Anna Rehman Linder | Board of Directors | 0 companies |
| Ole Ibsen | Board of Directors | 0 companies |
| Birgitte Bøgh-Sørensen | Board of Directors | 0 companies |
| Hans Christian Eberhard Groth Teisen | Board of Directors | 0 companies |
| Niels Thorborg | Board of Directors | 0 companies |
| John Morell Frellsen | Board of Directors | 0 companies |
| Ole Michael Friis | Chairman | 0 companies |
| Nicki Lund Kristensen | Board of Directors | 0 companies |